Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGF1 | P05230 | 2/20 | 0.45 |
| ▸ | FGF2 | P09038 | 2/20 | 0.45 |
| ▸ | VEGFA | P15692 | 2/20 | 0.45 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.38 |
| ▸ | TUBB | P07437 | 2/20 | 0.38 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.38 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.38 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.38 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.38 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.38 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.38 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.38 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.38 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.38 |
| ▸ | TUBA1C | Q9BQE3 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14410760 | 1.00 | FGF1 (0.45) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL8720284 | 0.89 | CA1 (0.49) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL28316892 | 0.88 | FGF1 (0.52) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL28315418 | 0.87 | FGF1 (0.41) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL20147260 | 0.83 | FGF1 (0.40) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL13057268 | 0.81 | FGF1 (0.44) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL2175355 | 0.81 | FGF1 (0.44) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL6929305 | 0.81 | FGF1 (0.44) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL6923504 | 0.81 | FGF1 (0.44) | FGF1FGF2VEGFAHPSECA1 | |
| SCHEMBL13057269 | 0.81 | SSTR1 (0.44) | FGF1FGF2VEGFAHPSECA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070219144-A1 | IMMUNOMODULATORY SACCHARIDE COMPOUNDS | UNIVERSITY OF ALBERTA | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219144-A1 | IMMUNOMODULATORY SACCHARIDE COMPOUNDS | MTX1, MTX2, CSGALNACT1 | FGF1 2391/4885FGF2 2234/4885VEGFA 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.